Altimmune Inc (ALT)

Altimmune Inc (ALT) produces promising results – US Post News - US Post News

US Post News

ALTIMMUNE, INC. (NASDAQ: ALT) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Altimmune, Inc. Investors of ... - GlobeNewswire

GlobeNewswire

Altimmune, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 5, 2024 to ... - PR Newswire

PR Newswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire

GlobeNewswire

3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics - sharewise

sharewise

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - Markets Insider

Markets Insider

3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics - Yahoo Finance

Yahoo Finance

Head-To-Head Review: Altimmune (NASDAQ:ALT) & Zymeworks (NYSE:ZYME) - Defense World

Defense World

ALT Deadline: ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit - PR Newswire

PR Newswire

If These 3 Words Are True, Altimmune's Weight Loss Candidate Could Beat Novo Nordisk's Wegovy

The Motley Fool

Lost Money on Altimmune, Inc.(ALT)? Join Class Action Suit Seeking Recovery – Contact The Gross Law Firm - The Malaysian Reserve

The Malaysian Reserve

Class Action Lawsuit against Altimmune, Inc. (NASDAQ:ALT) - MSN

MSN

Altimmune Inc (ALT)'s Day in Review: Closing at 6.39, Up by 2.08 – DWinneX - The Dwinnex

The Dwinnex

Class Action Lawsuit against Altimmune, Inc. (NASDAQ:ALT) - TipRanks.com - TipRanks

TipRanks

Class Action Lawsuit against Altimmune, Inc. (NASDAQ:ALT) - TipRanks.com - TipRanks

TipRanks

Deadline on July 5th coming up in Lawsuit for Investors in Altimmune, Inc. (NASDAQ: ALT) - openPR

openPR

Altimmune, Inc. (ALT): Why Are Hedge Funds Shorting This Biopharmaceutical Stock? - Insider Monkey

Insider Monkey

Altimmune, Inc. (ALT): Why Are Hedge Funds Shorting This Biopharmaceutical Stock? - Yahoo Finance

Yahoo Finance

Deadline on July 5th coming up in Lawsuit for Investors in Altimmune, Inc. (NASDAQ: ALT) - openPR

openPR

No longer a two-horse race: Obesity drug competition expands - BioWorld Online

BioWorld Online

IMMINENT ALT DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Altimmune, Inc. Investors to Join the Class ... - AccessWire

AccessWire

Altimmune Stock Is Rising Monday: What's Driving The Action? - MSN

MSN

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - The Malaysian Reserve

The Malaysian Reserve

Long Term Trading Analysis for (ALT) - Stock Traders Daily

Stock Traders Daily

Why Are Altimmune Shares Trading Lower Wednesday? - Altimmune (NASDAQ:ALT) - Benzinga

Benzinga

Altimmune Drops 15% After Sudden Death of Finance Chief - MarketWatch

MarketWatch

Dime Community Bancshares sets $65M subordinated notes offer By Investing.com - Investing.com

Investing.com

Altimmune CFO Richard Eisenstadt passes away By Investing.com - Investing.com Australia

Investing.com Australia

Altimmune CFO Richard Eisenstadt passes away By Investing.com - Investing.com

Investing.com

Altimmune CFO Richard Eisenstadt passes away By Investing.com - Investing.com UK

Investing.com UK

A look into Altimmune Inc (ALT)'s deeper side – Sete News - SETE News

SETE News

Altimmune CFO Richard Eisenstadt passes away unexpectedly - MM+M Online

MM+M Online

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Altimmune ... - GlobeNewswire

GlobeNewswire

Holzer & Holzer, LLC Reminds Shareholders of July 5, 2024 Lead Plaintiff Deadline in Altimmune, Inc. (ALT) Class ... - GlobeNewswire

GlobeNewswire

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - PR Newswire

PR Newswire

Altimmune Appoints Andrew Shutterly as New CFO - TipRanks.com - TipRanks

TipRanks

Altimmune Chief Financial Officer Richard Eisenstadt Dies - MarketWatch

MarketWatch

Altimmune CFO Richard Eisenstadt passes away (NASDAQ:ALT) - Seeking Alpha

Seeking Alpha

Altimmune Mourns Passing of Chief Financial Officer, Richard Eisenstadt - ForexTV.com

ForexTV.com

Altimmune Mourns Passing of Chief Financial Officer, Richard Eisenstadt - StockTitan

StockTitan

Altimmune Mourns Passing of Chief Financial Officer, Richard Eisenstadt - Yahoo Finance

Yahoo Finance

IMMINENT ALT DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Altimmune, Inc. Investors to Join the Class ... - AccessWire

AccessWire

Contact Levi & Korsinsky by July 5, 2024 Deadline to Join Class Action Against Altimmune, Inc.(ALT) - PR Newswire

PR Newswire

Altimmune (NASDAQ:ALT) Given “Buy” Rating at B. Riley - Defense World

Defense World

Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire

GlobeNewswire

Altimmune Target of Unusually Large Options Trading (NASDAQ:ALT) - Defense World

Defense World

Short ALT: Altimmune Inc. faces bearish rejection at major resistance, targeting recent lows - Invezz

Invezz

IMMINENT ALT DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Altimmune, Inc. Investors to Join the Class ... - AccessWire

AccessWire

Shareholders that lost money on Altimmune, Inc.(ALT) should contact The Gross Law Firm about pending Class Action ... - Marketscreener.com

Marketscreener.com

Shareholders that lost money on Altimmune, Inc.(ALT) should contact The Gross Law Firm about pending Class Action ... - PR Newswire

PR Newswire